| galantamine hydrobromide / Generic mfg. |
NCT00236574: A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment |
|
|
| Completed | 3 | 974 | US | Galantamine hydrobromide | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Dementia, Alzheimer Disease | | 11/03 | | |
NCT00236431: A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment |
|
|
| Completed | 3 | 1063 | US | Galantamine hydrobromide | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Dementia, Alzheimer Disease | | 12/03 | | |
NCT00240695: A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment |
|
|
| Completed | 3 | 724 | US | galantamine hydrobromide | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Cognition Disorder, Nervous System Diseases, Mental Disorders, Brain Diseases | | 05/04 | | |
